{"id":4422,"date":"2019-03-26T06:10:52","date_gmt":"2019-03-26T06:10:52","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4422"},"modified":"2019-03-26T06:10:52","modified_gmt":"2019-03-26T06:10:52","slug":"registre-international-des-maladies-histiocytaires-rares-irhdr","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/fr\/study_trials\/international-rare-histiocytic-disorders-registry-irhdr\/","title":{"rendered":"Registre international des maladies histiocytaires rares (IRHDR)"},"content":{"rendered":"<p><strong>Objectif de l'\u00e9tude :&nbsp;<\/strong> La cr\u00e9ation d\u2019un registre international des troubles histiocytaires rares (IRHDR) facilitera l\u2019uniformisation du diagnostic des troubles histiocytaires rares (RHD), ainsi que la collecte et l\u2019analyse des donn\u00e9es cliniques, \u00e9pid\u00e9miologiques, th\u00e9rapeutiques et de survie des patients atteints de RHD. Ce registre permettra \u00e9galement de b\u00e9n\u00e9ficier d\u2019expertises pathologiques et pourrait d\u00e9boucher sur de futures recommandations th\u00e9rapeutiques.\u00a0 De plus, l\u2019IRHDR peut servir de cadre \u00e0 de futurs essais cliniques, cr\u00e9ant ainsi d\u2019excellentes opportunit\u00e9s de recherche. Enfin, un lien anonymis\u00e9 entre les donn\u00e9es cliniques et les \u00e9tudes biologiques associ\u00e9es pourrait \u00eatre \u00e9tabli \u00e0 l\u2019avenir gr\u00e2ce \u00e0 l\u2019IRHDR.  Cela pourrait contribuer davantage \u00e0 la compr\u00e9hension de l\u2019\u00e9tiologie de ces maladies rares, ainsi qu\u2019\u00e0 l\u2019identification de cibles th\u00e9rapeutiques potentielles.<\/p>\n<p><strong>Chercheur principal :<\/strong>&nbsp; Oussama Abla, docteur en m\u00e9decine, 416-813-7879, oussama.abla@sickkids.ca \u2013 OU \u2013 Prerna Chopra, 416-813-7654 poste 202043, prerna.chopra@sickkids.ca<\/p>\n<p><strong>Participation demand\u00e9e au patient :<\/strong>&nbsp; Tout patient chez qui un ECD a \u00e9t\u00e9 diagnostiqu\u00e9 (vivant ou d\u00e9c\u00e9d\u00e9) peut \u00eatre inclus dans cet essai clinique \u00e0 condition qu'un \u00e9chantillon pathologique appropri\u00e9 soit disponible pour un examen centralis\u00e9.<\/p>\n<p><strong>Identifiant ClinicalTrials.gov :<\/strong> NCT02285582<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective:&nbsp; The creation of an International Rare Histiocytic Disorders Registry (IRHDR) will facilitate a uniform diagnosis of the RHD\u2019s, as well as the collection and analysis of the clinical, [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[35],"class_list":["post-4422","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-registry"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/study_trials\/4422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/media?parent=4422"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/study_trials_cat?post=4422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}